Hamid Reza Moein

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement particularly in node-positive patients, but optimal dose and schedule remain undetermined. Objectives. This study aimed to assess the feasibility of dose-dense epirubicin and cyclophosphamide followed by docetaxel in node-positive breast cancer.(More)
  • 1